Rocket Lab Corporation (RKLB)
Rocket Lab: This Pullback Is A Buying Opportunity
Rocket Lab Corporation remains a Buy despite a recent 18% pullback, with fading negative catalysts and compelling long-term growth prospects. RKLB's execution track record is solid, with 21 Electron launches in 2025 and successful integration of multiple acquisitions supporting end-to-end space capabilities. Completion of the $1 billion ATM program removes a significant supply overhang, positioning RKLB for potential appreciation as bullish catalysts emerge.
Rocket Lab: Don't Let This Buying Opportunity Go To Waste
Rocket Lab is rated as a Speculative Buy, as I note that the bullish narrative remains intact despite the Neutron launch delay to Q4. RKLB trades at a steep premium of 44x forward P/S, reflecting very high confidence in its progress and future launch capabilities. But little room for disappointment, though. Backlog surged 69% QoQ to $1.85B, but sustainability hinges on successful Neutron execution and monetization. Further delays may set the stock back further.
Rocket Lab Corporation (RKLB) Stock Falls Amid Market Uptick: What Investors Need to Know
In the most recent trading session, Rocket Lab Corporation (RKLB) closed at $66.32, indicating a -1.99% shift from the previous trading day.
RKLB's Neutron Launch Vehicle: Is It Driving the Next Phase of Growth?
Rocket Lab pushes into medium-lift launches with Neutron, aiming to expand beyond small satellites and capture growing demand for larger, complex space missions.
Rocket Lab Stock Rises 10.1% in 6 Months: What's Next for Investors?
RKLB climbs 10.1% in six months as defense demand and backlog growth drive momentum, but premium valuation and government exposure cloud near-term outlook.
SpaceX IPO Fever Hits — Here's the One Space Stock You Should Buy Now
With SpaceX ‘s confidential IPO filing and reports of a targeted valuation above $1.75 trillion — investors have boosted nearly every space stock in sight.
Rocket Lab Stock: Neutral View Amid Strong Demand and Execution Risks
RKLB balances a $1.85B backlog and rising defense demand with execution risks from Neutron delays, margin pressure, and supplier constraints shaping its outlook.
RKLB and Hypersonics: HASTE Missions Point to Defense Upside
Rocket Lab taps rising hypersonic demand with HASTE missions and SDA wins, boosting backlog visibility while supplier constraints and execution timing remain key risks.
Rocket Lab's Backlog Provides a Clear Path to 2026 Revenue Growth
RKLB's $1.85B backlog and rising launch cadence set a clear 2026 revenue path, even as timing and mix create near-term volatility in results.
Rocket Lab Is Up 15x in Two Years. Is It Too Late?
Rocket Lab ( NASDAQ :RKLB | RKLB Price Prediction ) was worth a mere $4.1 per share back in late March 2024.
RKLB Stock: Valuation Vs. Vision
Rocket Lab's chief performance indicator is the “time horizon” that its CEO, Sir Peter Beck, is able to focus investors on. This aspect isn't talked about much and is mostly hidden, yet it is the key factor influencing Rocket Lab's stock.
Rocket Lab CEO Peter Beck makes a statement as he takes a $799,999 pay cut
The company says it will take the money that would have gone toward Beck's future wages and bonuses and put it toward R&D projects.
